These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 17989120)
1. Interleukin-18 production and pulmonary function in COPD. Imaoka H; Hoshino T; Takei S; Kinoshita T; Okamoto M; Kawayama T; Kato S; Iwasaki H; Watanabe K; Aizawa H Eur Respir J; 2008 Feb; 31(2):287-97. PubMed ID: 17989120 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of interleukin-18 and its receptor in peripheral blood of patients with chronic obstructive pulmonary disease. Wang J; Liu X; Xie M; Xie J; Xiong W; Xu Y COPD; 2012 Aug; 9(4):375-81. PubMed ID: 22489883 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460 [TBL] [Abstract][Full Text] [Related]
4. Exhaled nitric oxide from lung periphery is increased in COPD. Brindicci C; Ito K; Resta O; Pride NB; Barnes PJ; Kharitonov SA Eur Respir J; 2005 Jul; 26(1):52-9. PubMed ID: 15994389 [TBL] [Abstract][Full Text] [Related]
5. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients]. Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637 [TBL] [Abstract][Full Text] [Related]
6. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease]. Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers. Zhang J; Chu S; Zhong X; Lao Q; He Z; Liang Y Int Immunopharmacol; 2013 Jan; 15(1):58-66. PubMed ID: 23127823 [TBL] [Abstract][Full Text] [Related]
8. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
9. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease]. He B; Zhao MW; Wang YZ; Liu XF; Yao WZ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264 [TBL] [Abstract][Full Text] [Related]
10. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172 [TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. Zhang L; Cheng Z; Liu W; Wu K COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276 [TBL] [Abstract][Full Text] [Related]
12. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients]. Xiao W; Tong WL; Ma DD Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049 [TBL] [Abstract][Full Text] [Related]
13. [The clinical characteristics of intra-acinar pulmonary artery inflammation and its effect on clinical parameters in smokers with normal lung function and patients with chronic obstructive pulmonary disease]. Lao QF; Zhong XN; He ZY; Liu GN; Lü ZL; Wan P Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):839-44. PubMed ID: 22321324 [TBL] [Abstract][Full Text] [Related]
14. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers. Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300 [TBL] [Abstract][Full Text] [Related]
15. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease. Pons AR; Sauleda J; Noguera A; Pons J; Barceló B; Fuster A; Agustí AG Eur Respir J; 2005 Jul; 26(1):60-6. PubMed ID: 15994390 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Xu L; Cai BQ; Zhu YJ Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474 [TBL] [Abstract][Full Text] [Related]
17. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Chu S; Zhong X; Zhang J; Lao Q; He Z; Bai J Int Immunopharmacol; 2011 Nov; 11(11):1780-8. PubMed ID: 21791252 [TBL] [Abstract][Full Text] [Related]
18. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis. Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508 [TBL] [Abstract][Full Text] [Related]
19. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and airway inflammation in severe exacerbations of COPD. Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]